U.S. gene sequencing company Illumina's (ILMN.O) plan to divest cancer diagnostic test maker Grail (GRAL.O), opens new tab received the green light from EU antitrust regulators on Friday after having blocked the deal two years ago.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,